1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
63171F92B34939D77652582130027D2A7
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/db-benchmarking-field-medical-field-outcomes-pricing-kol-engagement-strategies?opendocument
18
19opendocument
203.87.147.184
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




Products & Services Medical Affairs Medical Science Liaison

Benchmarking Field Medical & Field Outcomes and Pricing KOL Engagement Strategies

ID: 5489


Features:

6 Info Graphics

24 Data Graphics

217 Metrics


Pages/Slides: 37


Published: 2018


Delivery Format: Online PDF Document


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Buy Now

 


  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Non-members: Click here to review a complimentary excerpt from “Benchmarking Field Medical & Field Outcomes and Pricing KOL Engagement Strategies”

STUDY OVERVIEW


With growing demand for scientific and outcomes data in the healthcare industry, it is critical for pharmaceutical companies to develop effective thought leader engagement strategies for their field-based medical and outcomes/pricing group. Consequently, Medical Affairs leaders have turned to their field-based medical and outcomes/pricing teams to effectively serve this critical external stakeholder group.

Best Practices, LLC undertook this benchmarking research study to examine current industry trends and best practices for field-based medical and outcomes/pricing teams in North America, Europe, APAC and Emerging Markets. In particular, this study establishes benchmarks around virtual HCP engagement; field medical team deployment and reporting relationships; and activity levels and product coverage.

KEY TOPICS


1. In-Person vs. Virtual HCP Engagement

2. Structure & Leadership of Field-Based Medical Teams vs. Field-Based Outcomes and Pricing Teams

    • Deployment
    • Reporting Relationships
3. Activity Levels and Product Coverage

KEY METRICS

  • When do you first deploy field medical teams, when field medical team presence peaks, when field medical presence tapers?
  • Do you have a separate field outcomes & pricing group or is it rolled into field medical responsibilities?
  • Please estimate the size of medical expert / OL panel with which your high performing field medical staff regularly engage (on a per employee basis)
  • On average, how many products both in the market and in the development pipeline are actively supported per field medical employee?
  • Do your field medical employees cover products across different therapeutic areas, or within the same therapeutic area?
  • Do you file form 2253 for proactive resources used by your MSL team?

SAMPLE KEY FINDINGS

  • Companies Have Established Regular Engagement Levels For Thought Leaders: All the participants have an established weekly, monthly, quarterly or annual MSL thought leader engagement activity level within Europe and APAC regions. North America (81%) and emerging markets (75%) also have an established thought leader engagement activity level.

METHODOLOGY


Best Practices, LLC engaged 17 leaders with direct experience working with field medical and field outcomes and pricing teams from 15 leading bio-pharmaceutical companies through a benchmarking survey instrument. More than half of the benchmark partners serve at the level of director or above.


Industries Profiled:
Biopharmaceutical; Pharmaceutical; Biotech; Medical Device; Health Care; Clinical Research; Laboratories


Companies Profiled:
Avanir; Boehringer Ingelheim; Galderma; GlaxoSmithKline ; Janssen; Medtronic; Merck; QuintilesIMS; Roche; Sanofi; Sunovion; Takeda Pharmaceuticals; Tide Pharmaceutical Company; UCB Pharma; ViiV Healthcare


If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.